Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma

Mise à jour : Il y a 4 ans
Référence : NCT02843386

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

After the local treatment of the primary tumor (protonbeam-therapy, enucleation, external radiotherapy) patients with high risk of metastasis are randomized between: - Adjuvant chemotherapy with Fotemustin. - Observation Both groups are followed during 3 years for Metastasis- Free Survival, safety and tolerance of Fotemustin, quality of life, and Overall Survival.


Critère d'inclusion

  • Uveal Melanoma

Liens